0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Colchicine Market by Indication, Formulation, Route, End User, Distribution Channel, Dosage - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967649
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Colchicine market is experiencing significant transformation driven by clinical innovation, evolving payer frameworks, and expanding global reach. Senior decision-makers are navigating increased complexity in portfolio management and competitive strategy as new delivery methods and indications redefine the landscape.

Market Snapshot: Growth and Opportunity in the Colchicine Market

The Colchicine Market grew from USD 1.58 billion in 2024 to USD 1.71 billion in 2025. It is expected to continue growing at a CAGR of 7.86%, reaching USD 2.49 billion by 2030. This growth reflects greater adoption across established as well as emerging indications, fueled by ongoing clinical research and an expanding patient base. The Americas remain a major consumption hub, while Asia-Pacific is poised for the fastest expansion. A combination of established treatments, new formulations, and regional manufacturing is reshaping the market's competitive and operational environment.

Scope & Segmentation Analysis

This report provides a detailed view of the colchicine market landscape, examining critical segments and factors influencing adoption and value:

  • Indications: Gout, Behçet’s Disease, Pericarditis, Familial Mediterranean Fever
  • Formulations: Injectable (intramuscular, intravenous), Oral Capsule, Oral Tablet (extended release, standard release)
  • Routes of Administration: Oral, Parenteral (intramuscular, intravenous)
  • End Users: Hospitals, Clinics, Home Care Settings
  • Distribution Channels: Hospital Pharmacy, Retail Pharmacy (chain, independent), Online Pharmacy (direct-to-consumer, partner platforms)
  • Dosage Strengths: High Dose (1.8 mg, 2.4 mg), Standard Dose, Low Dose (0.3 mg, 0.6 mg)
  • Key Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, South Africa, Saudi Arabia, Turkey), Asia-Pacific (China, India, Japan, Australia, Southeast Asian nations)
  • Leading Companies: Teva Pharmaceutical Industries Limited, Sandoz International GmbH, Viatris Inc., Sun Pharmaceutical Industries Limited, Lupin Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Apotex Inc., Hetero Drugs Limited, Torrent Pharmaceuticals Limited

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Precision medicine and value-based care models are reshaping therapeutic protocols, particularly for rare autoinflammatory and cardiometabolic indications.
  • Novel delivery technologies, such as extended-release tablets and targeted injectables, are driving improvements in patient adherence and clinical outcomes.
  • Shifting payer strategies are compelling manufacturers to invest in real-world effectiveness data and pharmacoeconomic analysis to support market access.
  • Competitive dynamics are intensifying with the entry of biosimilars and generics, prompting alliances and innovative licensing arrangements for market retention.
  • Regional disparities in regulatory policy, disease prevalence, and reimbursement mechanisms require localized approaches for optimal penetration and growth.

Tariff Impact on Cost Structures

Recent tariff changes in the United States have led to heightened cost pressures, particularly on imported raw materials and excipients used in parenteral formulations. Manufacturers are adapting by diversifying suppliers, renegotiating distributor contracts, and enhancing domestic production capabilities. The need for agile supply chain strategies remains a priority as tariff volatility influences operational margins and pricing stability.

Methodology & Data Sources

This report integrates primary research, such as interviews with pharmaceutical executives, healthcare practitioners, and payers, alongside secondary analysis of clinical trial registries, regulatory filings, and proprietary databases. Validation processes, expert panels, and triangulation of quantitative data ensure data integrity for strategic planning.

Why This Report Matters

  • Enables C-suite leaders to identify growth opportunities and assess risk in a competitive, evolving market.
  • Supports strategic planning through actionable intelligence on product innovation, supply chain adaptation, and regional market entry.
  • Facilitates informed decisions regarding investments, partnerships, and operational adjustments in response to regulatory and payer dynamics.

Conclusion

The Colchicine Market is entering a dynamic phase defined by therapeutic innovation, cost pressures, and globalization. Executives who align portfolio, pricing, and regional strategies will be better equipped to capture value and strengthen market position in this evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Colchicine Market, by Indication
8.1. Introduction
8.2. Behçet’s Disease
8.3. Familial Mediterranean Fever
8.4. Gout
8.5. Pericarditis
9. Colchicine Market, by Formulation
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Intravenous
9.3. Oral Capsule
9.4. Oral Tablet
9.4.1. Extended Release
9.4.2. Standard Release
10. Colchicine Market, by Route
10.1. Introduction
10.2. Oral
10.3. Parenteral
10.3.1. Intramuscular
10.3.2. Intravenous
11. Colchicine Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care Settings
11.4. Hospitals
12. Colchicine Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.3.1. Direct-to-Consumer
12.3.2. Partner Platforms
12.4. Retail Pharmacy
12.4.1. Chain
12.4.2. Independent
13. Colchicine Market, by Dosage
13.1. Introduction
13.2. High Dose
13.2.1. 1.8 mg
13.2.2. 2.4 mg
13.3. Low Dose
13.3.1. 0.3 mg
13.3.2. 0.6 mg
13.4. Standard Dose
14. Americas Colchicine Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Colchicine Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Colchicine Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Teva Pharmaceutical Industries Limited
17.3.2. Sandoz International GmbH
17.3.3. Viatris Inc.
17.3.4. Sun Pharmaceutical Industries Limited
17.3.5. Lupin Limited
17.3.6. Dr. Reddy's Laboratories Limited
17.3.7. Cipla Limited
17.3.8. Apotex Inc.
17.3.9. Hetero Drugs Limited
17.3.10. Torrent Pharmaceuticals Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. COLCHICINE MARKET MULTI-CURRENCY
FIGURE 2. COLCHICINE MARKET MULTI-LANGUAGE
FIGURE 3. COLCHICINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL COLCHICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COLCHICINE MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COLCHICINE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COLCHICINE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COLCHICINE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COLCHICINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COLCHICINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. COLCHICINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. COLCHICINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COLCHICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COLCHICINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL COLCHICINE MARKET SIZE, BY BEHÇET’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COLCHICINE MARKET SIZE, BY FAMILIAL MEDITERRANEAN FEVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COLCHICINE MARKET SIZE, BY GOUT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COLCHICINE MARKET SIZE, BY PERICARDITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COLCHICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COLCHICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COLCHICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COLCHICINE MARKET SIZE, BY ORAL CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COLCHICINE MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COLCHICINE MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COLCHICINE MARKET SIZE, BY STANDARD RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COLCHICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COLCHICINE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COLCHICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COLCHICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COLCHICINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COLCHICINE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COLCHICINE MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COLCHICINE MARKET SIZE, BY PARTNER PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COLCHICINE MARKET SIZE, BY CHAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL COLCHICINE MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL COLCHICINE MARKET SIZE, BY HIGH DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL COLCHICINE MARKET SIZE, BY 1.8 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL COLCHICINE MARKET SIZE, BY 2.4 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL COLCHICINE MARKET SIZE, BY LOW DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL COLCHICINE MARKET SIZE, BY 0.3 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL COLCHICINE MARKET SIZE, BY 0.6 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL COLCHICINE MARKET SIZE, BY STANDARD DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. CANADA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 82. CANADA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 83. CANADA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 84. CANADA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 85. CANADA COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. CANADA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. CANADA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 88. CANADA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 89. CANADA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 90. CANADA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 91. CANADA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 92. MEXICO COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. MEXICO COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 94. MEXICO COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 96. MEXICO COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 98. MEXICO COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. MEXICO COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. MEXICO COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 101. MEXICO COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 102. MEXICO COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 104. MEXICO COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 158. GERMANY COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. GERMANY COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 160. GERMANY COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 161. GERMANY COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 162. GERMANY COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 163. GERMANY COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 164. GERMANY COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. GERMANY COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. GERMANY COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 167. GERMANY COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 168. GERMANY COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 169. GERMANY COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 170. GERMANY COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 172. FRANCE COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 173. FRANCE COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 175. FRANCE COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 177. FRANCE COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. FRANCE COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. FRANCE COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 180. FRANCE COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 181. FRANCE COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 182. FRANCE COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 183. FRANCE COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 197. ITALY COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 198. ITALY COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 199. ITALY COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 200. ITALY COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 201. ITALY COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 202. ITALY COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 203. ITALY COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. ITALY COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. ITALY COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 206. ITALY COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 207. ITALY COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 208. ITALY COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 209. ITALY COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 210. SPAIN COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. SPAIN COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 212. SPAIN COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 213. SPAIN COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 214. SPAIN COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 215. SPAIN COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 216. SPAIN COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SPAIN COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. SPAIN COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 219. SPAIN COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 220. SPAIN COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 221. SPAIN COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 222. SPAIN COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 262. DENMARK COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 263. DENMARK COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 264. DENMARK COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 265. DENMARK COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 266. DENMARK COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 267. DENMARK COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 268. DENMARK COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. DENMARK COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. DENMARK COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 271. DENMARK COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 272. DENMARK COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 273. DENMARK COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 274. DENMARK COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 278. NETHERLANDS COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 288. QATAR COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 289. QATAR COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 290. QATAR COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 291. QATAR COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 292. QATAR COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 293. QATAR COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 294. QATAR COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. QATAR COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. QATAR COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 297. QATAR COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 298. QATAR COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 299. QATAR COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 300. QATAR COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 301. FINLAND COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 302. FINLAND COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 303. FINLAND COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 304. FINLAND COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 305. FINLAND COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 306. FINLAND COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 307. FINLAND COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. FINLAND COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 309. FINLAND COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 310. FINLAND COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 311. FINLAND COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 312. FINLAND COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 313. FINLAND COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 314. SWEDEN COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 315. SWEDEN COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 316. SWEDEN COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 317. SWEDEN COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 318. SWEDEN COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 326. SWEDEN COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 327. NIGERIA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 328. NIGERIA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 329. NIGERIA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 330. NIGERIA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 337. NIGERIA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 338. NIGERIA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 339. NIGERIA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 340. EGYPT COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 341. EGYPT COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 342. EGYPT COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 343. EGYPT COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 344. EGYPT COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 345. EGYPT COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 346. EGYPT COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 347. EGYPT COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 348. EGYPT COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 349. EGYPT COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 350. EGYPT COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 351. EGYPT COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 352. EGYPT COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 353. TURKEY COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 354. TURKEY COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 355. TURKEY COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 356. TURKEY COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 357. TURKEY COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 358. TURKEY COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 359. TURKEY COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 360. TURKEY COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 361. TURKEY COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 362. TURKEY COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 363. TURKEY COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 364. TURKEY COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 365. TURKEY COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 366. ISRAEL COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 367. ISRAEL COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 368. ISRAEL COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 369. ISRAEL COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 370. ISRAEL COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 371. ISRAEL COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 372. ISRAEL COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 373. ISRAEL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 374. ISRAEL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 375. ISRAEL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 376. ISRAEL COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 377. ISRAEL COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2030 (USD MILLION)
TABLE 378. ISRAEL COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2030 (USD MILLION)
TABLE 379. NORWAY COLCHICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 380. NORWAY COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 381. NORWAY COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 382. NORWAY COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2030 (USD MILLION)
TABLE 383. NORWAY COLCHICINE MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
TABLE 384. NORWAY COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 385. NORWAY COLCHICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 386. NORWAY COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 387. NORWAY COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 38

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Colchicine market report include:
  • Teva Pharmaceutical Industries Limited
  • Sandoz International GmbH
  • Viatris Inc.
  • Sun Pharmaceutical Industries Limited
  • Lupin Limited
  • Dr. Reddy's Laboratories Limited
  • Cipla Limited
  • Apotex Inc.
  • Hetero Drugs Limited
  • Torrent Pharmaceuticals Limited

Table Information

This website uses cookies to ensure you get the best experience. Learn more